Tittarelli, R., Pellegrini, M., Scarpellini, M
Patients taking Zepbound should understand which symptoms require immediate medical attention versus those that warrant routine follow-up
About SELECT SELECT (Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity) was a randomised, double-blind, parallel-group, placebo-controlled trial designed to evaluate the efficacy of semaglutide 2.4 mg versus placebo as an adjunct to standard of care for reducing the risk of MACE in people with established CVD with overweight or obesity with no prior history of diabetes
Weight Watchers Ozempic Membership: The WW App With either program the Points Program or the GLP-1 Program you get your own profile with the Weight Watchers app
The Yellow Card scheme enables the MHRA to monitor safety concerns such as suspected side effects or adverse incidents involving healthcare products
Our GLP-1 Daily Support supplement is designed to help provide the nutrients your body needs while on a reduced-calorie diet, potentially smoothing out some of the common hurdles during the early weeks of treatment